Screening for STIs

  • High-Yield
    • Chlamydia & Gonorrhea: All sexually active females 24 yo and females 25 yo at increased risk.
    • HIV: Screening for all individuals aged 15–65 yo at least once; high-risk groups screened annually or more frequently.
    • Syphilis: High-risk individuals and all pregnant women at 1st prenatal visit (repeat at 28 wks & delivery if high risk). c
    • Hepatitis B & C: Universal HCV screening (all adults 18–79 yo); HBV screening for high-risk individuals and pregnant women.
  • Chlamydia trachomatis & Neisseria gonorrhoeae
    • Screening targets:
      • Females ≤ 24 yo: Annual routine screening.
      • Females ≥ 25 yo: Annual screening only if high risk (e.g., new/multiple partners).
      • MSM: Annual screening at all exposed sites (pharyngeal, rectal, urethral).
      • Pregnancy: All pts at 1st prenatal visit (repeat in 3rd trimester if < 25 yo or high risk).
    • Test: NAAT (first-catch urine or site-specific swab).
  • HIV (Human Immunodeficiency Virus)
    • Screening targets:
      • General population: Universal 1-time screening for ages 15–65 yo.
      • High-risk (MSM, IVDU): At least annually.
      • Pregnancy: All pts at 1st prenatal visit.
    • Test: 4th-generation HIV-1/2 Ag/Ab combo assay confirm w/ HIV-1/2 differentiation assay.
  • Syphilis (Treponema pallidum)
    • Screening targets: High-risk adults (MSM, IVDU) and all pregnant pts at 1st prenatal visit (repeat at 28–32 wks and delivery if high risk).
    • Test: Nontreponemal test (RPR/VDRL) confirm w/ Treponemal test (FTA-ABS/TP-PA).
  • Hepatitis B & C Viruses (HBV & HCV)
    • HBV: Screen all pregnant pts (1st visit) and high-risk adults with HBsAg.
    • HCV: Universal 1-time screening for all adults 18–79 yo and each pregnancy with HCV Ab ( HCV RNA PCR if (+)).
  • Cervical Cancer & HPV
    • < 21 yo: No screening regardless of sexual activity.
    • 21–29 yo: Pap smear q3y alone (no HPV co-testing).
    • 30–65 yo: Pap q3y OR hrHPV q5y OR co-testing q5y.
    • > 65 yo / Post-hysterectomy (for benign indications): Discontinue if adequate prior negative screens and low risk.
  • Herpes Simplex Virus (HSV) & Trichomoniasis
    • HSV: Routine screening NOT recommended in asymptomatic pts.
    • Trichomonas: Screen annually in HIV(+) females (NAAT or wet mount).